FDA Inspection 1178333 — Andrew Dean
The FDA completed an inspection of Andrew Dean on August 5, 2022 in Subiaco. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 5, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Subiaco (Australia)
Additional Details
Clinical Investigator (CI)